TB-IRIS after initiation of antiretroviral therapy is associated with expansion of preexistent th1 responses against mycobacterium tuberculosis antigens

Journal of Acquired Immune Deficiency Syndromes

Volumn 64, Issue 3, 2013, Pages 241-248

  Vignesh, Ramachandran ^a   Kumarasamy, Nagalingeswaran ^a   Lim, Andrew ^b   Solomon, Suniti ^a   Murugavel, Kailapuri G ^a   Balakrishnan, Pachamuthu ^a   Solomon, Sunil S ^a,c   Mayer, Kenneth H ^d   Swathirajan, Chinnambedu R ^a   Chandrasekaran, Ezhilarasi ^a   Pradeep, Ambrose ^a   Poongulali, Selvamuthu ^a   Benson, Constance A ^e   French, Martyn A ^b  

^a VHS Medical Centre India   (India)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HIV AIDS; IRIS; TB IRIS; tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; EARLY SECRETORY ANTIGENIC TARGET 6; ETHAMBUTOL; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 2; ISONIAZID; MYCOBACTERIUM ANTIGEN; PYRAZINAMIDE; RIFAMPICIN; TUBERCULIN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BACTERIAL ANTIGEN; CCR5 PROTEIN, HUMAN; CD3 ANTIGEN; CXCL10 PROTEIN, HUMAN; CXCR3 PROTEIN, HUMAN; INTERLEUKIN 10; MYCOBACTERIUM TUBERCULOSIS ANTIGENS;

ADULT; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LUNG TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; TH17 CELL; TREATMENT RESPONSE; TUBERCULOSIS ASSOCIATED IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; AIDS RELATED COMPLEX; CD8+ T LYMPHOCYTE; CELL MOTION; DRUG EFFECTS; EPIDEMIOLOGY; FLOW CYTOMETRY; HIV INFECTIONS; IMMUNOLOGY; INDIA; METABOLISM; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; TH1 CELL; TUBERCULOSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTIGENS, BACTERIAL; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CHEMOKINE CXCL10; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INDIA; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-2; MALE; PROSPECTIVE STUDIES; RECEPTORS, CCR5; RECEPTORS, CXCR3; TH1 CELLS; TUBERCULOSIS;

EID: 84886387241     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31829f6df2     Document Type: Conference Paper

References (37)

1. National AIDS Control Organization (NACO). HIV declining in India; new infections reduced by 50%from 2000-2009; sustained focus on prevention required. New Delhi, India. 2010. Available at: http://www.nacoonline.org/upload/ HomePage/NACO%20Press%20Release%20on%20HIV%20Estimates.pdf. Accessed March 4, 2013.
2. World Health Organization. Global Tuberculosis Report. 2012. Available at: http://www.who.int/iris/bitstream/10665/75938/1/9789241564502-eng.pdf.
3. Kumarasamy N, Solomon S, Flanigan TP, et al. Natural history of human immunodeficiency virus disease in southern India. Clin Infect Dis. 2003; 36:79-85.
4. Suthar AB, Lawn SD, del Amo J, et al. Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS Med. 2012;9:e1001270.
5. Kumarasamy N, Solomon S, Chaguturu SK, et al. The changing natural history of HIV disease: before and after the introduction of generic antiretroviral therapy in southern India. Clin Infect Dis. 2005;41: 1525-1528.
6. Meintjes G, Lawn SD, Scano F, et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis. 2008;8:516-523.
7. Blanc F-X, Sok T, Laureillard D, et al. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med. 2011;365:1471-1481.
8. Havlir DV, Kendall MA, Ive P, et al. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med. 2011;365:1482-1491.
9. Naidoo K, Yende-Zuma N, Padayatchi N, et al. The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial. Ann Intern Med. 2012; 157:313-324.
10. Burman W, Weis S, Vernon A, et al. Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis. Int J Tuberc Lung Dis. 2007;11:1282-1289.
11. Meintjes G, Rangaka MX, Maartens G, et al. Novel relationship between tuberculosis immune reconstitution inflammatory syndrome and antitubercular drug resistance. Clin Infect Dis. 2009;48:667-676.
12. Marais S, Meintjes G, Pepper DJ, et al. Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome. Clin Infect Dis. 2013;56:450-460.
13. Conesa-Botella A, Loembé MM, Manabe YC, et al. Urinary lipoarabinomannan as predictor for the tuberculosis immune reconstitution inflammatory syndrome. J Acquir Immune Defic Syndr. 2011;58:463-468.
14. Bourgarit A, Carcelain G,Martinez V, et al. Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients. AIDS. 2006;20:F1-F7.
15. Bourgarit A, Carcelain G, Samri A, et al. Tuberculosis-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin- specific CD4 Th1 cells and KIR-negative gamma delta T cells. J Immunol. 2009;183:3915-3923.
16. Tan DBA, Yong YK, Tan HY, et al. Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis. HIV Med. 2008;9:307-316.
17. Mahnke YD, Greenwald JH, DerSimonian R, et al. Selective expansion of polyfunctional pathogen-specific CD4(+) T cells in HIV-1-infected patients with immune reconstitution inflammatory syndrome. Blood. 2012;119:3105-3112.
18. Barber DL, Mayer-Barber KD, Antonelli LRV, et al. Th1-driven immune reconstitution disease in Mycobacterium avium-infected mice. Blood. 2010;116:3485-3493.
19. Meintjes G, Wilkinson KA, Rangaka MX, et al. Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome. Am J Respir Crit Care Med. 2008;178:1083-1089.
20. Elliott JH, Vohith K, Saramony S, et al. Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy. J Infect Dis. 2009;200:1736-1745.
21. Tieu HV, Ananworanich J, Avihingsanon A, et al. Immunologic markers as predictors of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV and tuberculosis coinfected persons in Thailand. AIDS Res Hum Retroviruses. 2009;25:1083-1089.
22. National AIDS Control Organization. Antiretroviral therapy guidelines for HIV-infected adults and adolescents including post-exposure prophylaxis. New Delhi, India. 2007. Available at: http://www.nacoonline.org/upload/ Policies%20&%20Guidelines/1. %20Antiretroviral%20Therapy%20Guidelines%20for%20HIV- Infected%20Adults%20and%20Adolescents%20Including%20Post-exposure.pdf. Accessed February 6, 2013.
23. Kapogiannis BG, Henderson SL, Nigam P, et al. Defective IL-2 production by HIV-1-specific CD4 and CD8 T cells in an adolescent/young adult cohort. AIDS Res Hum Retroviruses. 2006;22:272-282.
24. Kannanganat S, Kapogiannis BG, Ibegbu C, et al. Human immunodeficiency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines. J Virol. 2007;81:12071-12076.
25. Schluger NW, Perez D, Liu YM. Reconstitution of immune responses to tuberculosis in patients with HIV infection who receive antiretroviral therapy. Chest. 2002;122:597-602.
26. Tadokera R, Meintjes G, Skolimowska KH, et al. Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome. Eur Respir J. 2011;37:1248-1259.
27. Oliver BG, Elliott JH, Price P, et al. Tuberculosis after commencing antiretroviral therapy for HIV infection is associated with elevated CXCL9 and CXCL10 responses to Mycobacterium tuberculosis antigens. Acquir Immune Defic Syndr. 2012;61:287-292.
28. Azzurri A, Sow OY, Amedei A, et al. IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection. Microbes Infect. 2005;7:1-8.
29. Ruhwald M, Bodmer T, Maier C, et al. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur Respir J. 2008;32:1607-1615.
30. Ferrero E, Biswas P, Vettoretto K, et al. Macrophages exposed to Mycobacterium tuberculosis release chemokines able to recruit selected leukocyte subpopulations: focus on gamma delta cells. Immunology. 2003;108:365-374.
31. Oliver BG, Elliott JH, Price P, et al. Mediators of innate and adaptive immune responses differentially affect immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy. J Infect Dis. 2010;202:1728-1737.
32. Maxwell JR, Yadav R, Rossi RJ, et al. IL-18 bridges innate and adaptive immunity through IFN-gamma and the CD134 pathway. J Immunol. 2006;177:234-245.
33. Worsley CM, Suchard MS, Stevens WS, et al. Multi-analyte profiling of ten cytokines in South African HIV-infected patients with immune reconstitution inflammatory syndrome (IRIS). AIDS Res Ther. 2010;7:36.
34. Haddow LJ, Dibben O, Moosa M-YS, et al. Circulating inflammatory biomarkers can predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS. 2011;25:1163-1174.
35. Nicol MP, Pienaar D, Wood K, et al. Enzyme-linked immunospot assay responses to early secretory antigenic target 6, culture filtrate protein 10, and purified protein derivative among children with tuberculosis: implications for diagnosis and monitoring of therapy. Clin Infect Dis. 2005;40: 1301-1308.
36. Syrbe U, Siveke J, Hamann A. Th1/Th2 subsets: distinct differences in homing and chemokine receptor expression? Springer Semin Immunopathol. 1999;21:263-285.
37. Santucci MB, Bocchino M, Garg SK, et al. Expansion of CCR5+ CD4+ T-lymphocytes in the course of active pulmonary tuberculosis. Eur Respir J. 2004;24:638-643.